跳至主要内容
临床试验/JPRN-jRCT2080220293
JPRN-jRCT2080220293未知3 期

Clinical study to assess the efficacy and safety of TA-650 in patients with active ulcerative colitis

Mitsubishi Tanabe Pharma Corporation0 个研究点开始时间: 2006年8月24日最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • [Inclusion criteria]
  • Patients with active ulcerative colitis, who have failed to response, have failed to successfully taper or have medical complications to other existing medications, 16 years and above, male and female.
  • [Exclusion criteria]
  • Patients who have received infliximab in the past, have a history of serious infection which caused hospitalization within 6 months before the registration, have an active tuberculosis, have a complication or a history of malignancy within 5 years before the registration.

排除标准

  • 未提供

研究者

相似试验